pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
BIOMARIN PHARMACEUTICAL INC ($BMRN) · news · pharmadog
← back to BIOMARIN PHARMACEUTICAL INC
News mentioning $BMRN
10
stories
1d
7 biopharma M&A deals where layoffs followed
biospace
1d
Kolon TissueGene cuts 37 US staffers after Phase 3 fail
biospace
2d
BioMarin acquires experimental drug for rare bone disorder in $275M deal
biopharma dive
2d
BioMarin bulks up bone unit with $275M Alesta buyout to challenge AstraZeneca
fiercebiotech
8d
Silence cashes in on ‘differentiated’ data; UK reaffirms support for childhood vaccines
biopharma dive
10d
BioMarin axes asset from $270M Inozyme takeover, ending run in rare metabolic indication
biospace
13d
BioMarin axes $270M rare disease asset after missing phase 3 endpoint
fiercebiotech
15d
The top 12 companies hiring in biopharma now
biospace
Jul 16, 26
Spurred by deep cuts and M&A activity, H1 layoffs could oust 14,000+ in biopharma
biospace
May 19, 26
BioMarin drug acquired in buyout misses goal in rare disease study
biopharma dive
